000 02387 a2200613 4500
005 20250515181430.0
264 0 _c20101026
008 201010s 0 0 eng d
022 _a1522-1547
024 7 _a10.1152/ajpgi.00162.2009
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aColmenero, Jordi
245 0 0 _aEffects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C.
_h[electronic resource]
260 _bAmerican journal of physiology. Gastrointestinal and liver physiology
_cOct 2009
300 _aG726-34 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase IV; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAdaptor Proteins, Signal Transducing
650 0 4 _aAdaptor Proteins, Vesicular Transport
_xgenetics
650 0 4 _aAdministration, Oral
650 0 4 _aAngiotensin II Type 1 Receptor Blockers
_xadministration & dosage
650 0 4 _aBiopsy, Needle
650 0 4 _aCollagen
_xgenetics
650 0 4 _aDown-Regulation
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation, Enzymologic
_xdrug effects
650 0 4 _aHepatitis C, Chronic
_xcomplications
650 0 4 _aHumans
650 0 4 _aInflammation Mediators
_xmetabolism
650 0 4 _aLiver
_xdrug effects
650 0 4 _aLiver Cirrhosis
_xdrug therapy
650 0 4 _aLosartan
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMatrix Metalloproteinase 2
_xgenetics
650 0 4 _aMiddle Aged
650 0 4 _aNADPH Oxidases
_xgenetics
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aSeverity of Illness Index
650 0 4 _aSpain
650 0 4 _aTime Factors
650 0 4 _aTreatment Outcome
650 0 4 _aUrokinase-Type Plasminogen Activator
_xgenetics
650 0 4 _arac1 GTP-Binding Protein
_xgenetics
700 1 _aBataller, Ramón
700 1 _aSancho-Bru, Pau
700 1 _aDomínguez, Marlene
700 1 _aMoreno, Montserrat
700 1 _aForns, Xavier
700 1 _aBruguera, Miquel
700 1 _aArroyo, Vicente
700 1 _aBrenner, David A
700 1 _aGinès, Pere
773 0 _tAmerican journal of physiology. Gastrointestinal and liver physiology
_gvol. 297
_gno. 4
_gp. G726-34
856 4 0 _uhttps://doi.org/10.1152/ajpgi.00162.2009
_zAvailable from publisher's website
999 _c19037108
_d19037108